Gainers
- ChemoCentryx, Inc. (NASDAQ:CCXI) shares climbed 281.3% to close at $30.73 on Tuesday after the company announced the pivotal phase-III ADVOCATE trial of avacopan for the treatment of patients with ANCA-associated vasculitis met both primary endpoints.
- Baudax Bio, Inc. (NASDAQ:BXRX) gained 50.4% to close at $6.86
- ToughBuilt Industries, Inc. (NASDAQ:TBLT) rose 43.8% to close at $0.23 after the company announced its Amazon storefront achieved revenues of $1.8 million in the U.S. and Canada in its first 7 months of operation.
- BioCardia, Inc. (NASDAQ:BCDA) gained 33.5% to close at $4.70.
- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) rose 28.7% to close at $4.62.
- Akerna Corp. (NASDAQ:KERN) shares climbed 26.6% to close at $7.76.
- GTT Communications, Inc. (NYSE:GTT) rose 24.5% to close at $6.82.
- Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) gained 21.2% to close at $5.14.
- Power REIT (NYSE:PW) shares rose 20.3% to close at $10.06.
- Pier 1 Imports, Inc. (NYSE:PIR) climbed 19.8% to close at $9.20.
- Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) gained 18.8% to close at $67.70 after the company reported FY19 EPS and sales results are up from the same quarter last year.
- DICK'S Sporting Goods, Inc. (NYSE:DKS) gained 18.6% to close at $46.77 after the company reported better-than-expected Q3 EPS and sales results. The company also raised FY19 EPS guidance above analyst estimates.
- Ardelyx, Inc. (NASDAQ:ARDX) climbed 18.2% to close at $7.54 after Kyowa Kirin made a $20 million equity investment in the company at $6.96 for 2,873,563 shares.
- Nutanix, Inc. (NASDAQ:NTNX) shares surged 16.4% to close at $33.47 after the company reported better-than-expected Q1 EPS and sales results.
- Xenon Pharmaceuticals Inc. (NASDAQ:XENE) gained 16.4% to close at $11.66.
- InflaRx N.V. (NASDAQ:IFRX) shares gained 16.2% to close at $3.08.
- Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) surged 14.7% to close at $7.10.
- Chico's FAS, Inc. (NYSE:CHS) gained 14.1% to close at $4.77 after the company reported better-than-expected Q3 EPS and sales results.
- Marker Therapeutics, Inc. (NASDAQ:MRKR) rose 14% to close at $3.33.
- Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) climbed 13.7% to close at $3.23.
- Capstone Turbine Corporation (NASDAQ:CPST) gained 13.4% to close at $4.33.
- Arcadia Biosciences, Inc. (NASDAQ:RKDA) climbed 12.2% to close at $5.16 in sympathy with VEXT after the company reported Q3 Sales results up from last year.
- HF Foods Group Inc. (NASDAQ:HFFG) gained 11.3% to close at $23.50.
- NIO Inc. (NYSE:NIO) rose 11.2% to close at $2.28.
- Viela Bio, Inc. (NASDAQ:VIE) gained 11.1% to close at $29.73.
- ObsEva SA (NASDAQ:OBSV) shares rose 10.5% to close at $3.68.
- Precision BioSciences, Inc. (NASDAQ:DTIL) gained 10.5% to close at $16.16.
- Wanda Sports Group Company Limited (NASDAQ:WSG) shares surged 10.4% to close at $3.18.
- Repro Med Systems, Inc. (NASDAQ:KRMD) gained 10.3% to close at $4.49.
- Stage Stores, Inc. (NYSE:SSI) rose 10.3% to close at $4.94.
- Alector, Inc. (NASDAQ:ALEC) gained 10% to close at $18.16.
- Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) surged 10% to close at $32.52.
- Best Buy Co., Inc. (NYSE:BBY) rose 9.9% to close at $81.57 after the company reported better-than-expected Q3 EPS and sales results. The company also issued Q4 EPS and raised FY20 EPS guidance above analyst estimates.
- Dycom Industries, Inc. (NYSE:DY) shares gained 8.8% to close at $54.36 after reporting upbeat Q3 results.
- Burlington Stores, Inc. (NYSE:BURL) rose 8.5% to close at $225.97 after the company reported better-than-expected Q3 EPS results. The company also raised its FY19 sales guidance.
- Safehold Inc. (NYSE:SAFE) shares climbed 7% to close at $41.07. Safehold will replace Oritani Financial in the S&P SmallCap 600 on Tuesday, December 3.
- BlueLinx Holdings Inc. (NYSE:BXC) rose 5.3% to close at $10.06 on Tuesday after falling 23.23% on Monday.
Check out these big penny stock gainers and losers
Losers
- MTS Systems Corporation (NASDAQ:MTSC) shares dropped 22.5% to close at $46.92 after the company reported downbeat Q4 earnings and reported the purchase of R&D's operating entities for upfront payment of $55 million.
- YayYo, Inc. (NASDAQ:YAYO) shares declined 22.2% to close at $2.00.
- Movado Group, Inc. (NYSE:MOV) shares tumbled 20.4% to close at $20.05 on Tuesday after the company reported worse-than-expected Q3 EPS and sales results. The company also cut its FY20 sales guidance below the analyst estimates.
- X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) fell 16.8% to close at $2.75. X4 Pharmaceuticals priced its $65 million public offering of common stock and Class B warrants.
- Titan Machinery Inc. (NASDAQ:TITN) dropped 15.5% to close at $15.23 after the company reported downbeat Q3 results and narrowed FY20 EPS guidance.
- Dollar Tree, Inc. (NASDAQ:DLTR) dipped 15.2% to close at $95.26 after the company reported worse-than-expected Q3 EPS results. The company also narrowed its FY19 sales guidance to the lower end of analyst estimates.
- Kazia Therapeutics Limited (NASDAQ:KZIA) fell 14.4% to close at $4.80 after declining24.19% on Monday.
- Airgain, Inc. (NASDAQ:AIRG) fell 13.2% to close at $8.66 after the company reported that CFO Anil Doradla is leaving the company.
- Palo Alto Networks, Inc. (NYSE:PANW) fell 12% to close at $220.37 after the company issued worse-than-expected FY20 and Q2 EPS guidance.
- Exterran Corporation (NYSE:EXTN) shares dropped 11.5% to close at $5.57.
- Karuna Therapeutics, Inc. (NASDAQ:KRTX) dipped 11.3% to close at $72.88.
- Diebold Nixdorf, Incorporated (NYSE:DBD) shares declined 10.7% to close at $7.10.
- Amneal Pharmaceuticals, Inc. (NYSE:AMRX) dropped 10.1% to close at $3.04.
- Whiting Petroleum Corporation (NYSE:WLL) dipped 9.9% to close at $4.89 after UBS maintained a Neutral rating on the stock and lowered the price target from $21 to $6.5.
- Fulcrum Therapeutics, Inc. (NASDAQ:FULC) dropped 9.9% to close at $13.52.
- Fuwei Films (Holdings) Co., Ltd. (NASDAQ:FFHL) shares slipped 9.8% to close at $3.30.
- Beacon Roofing Supply, Inc. (NASDAQ:BECN) fell 9.7% to close at $30.15 after the company reported worse-than-expected Q4 EPS and sales results.
- The Peck Company Holdings, Inc. (NASDAQ:PECK) dropped 9.7% to close at $2.43.
- Hewlett Packard Enterprise Company (NYSE:HPE) fell 8.5% to close at $15.97 after the company reported worse-than-expected Q4 sales results.
- Aurora Mobile Limited (NASDAQ:JG) dipped 8.3% to close at $2.75.
- RAPT Therapeutics, Inc. (NASDAQ:RAPT) dipped 7.5% to close at $27.26.
- Range Resources Corporation (NYSE:RRC) dropped 7.5% to close at $3.59.
- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) dropped 6.1% to close at $0.58 after Raymond James downgraded the stock from Outperform to Market Perform.
ALECAlector Inc
$1.39-%
AMRXAmneal Pharmaceuticals Inc
$12.15-0.16%
ARDXArdelyx Inc
$6.010.17%
ARWRArrowhead Pharmaceuticals Inc
$64.56-0.15%
AUPHAurinia Pharmaceuticals Inc
$15.70-0.95%
BBYBest Buy Co Inc
$72.11-0.70%
BCDABioCardia Inc
$1.26-1.56%
BURLBurlington Stores Inc
$260.90-%
BXCBlueLinx Holdings Inc
$63.52-%
CPSTCalamos S&P 500 Structured Alt Protection ETF September
$26.96-0.06%
DBDDiebold Nixdorf Inc
$67.240.33%
DKSDick's Sporting Goods Inc
$209.93-%
DLTRDollar Tree Inc
$131.15-%
DTILPrecision BioSciences Inc
$4.82-%
DYDycom Industries Inc
$347.61-%
FULCFulcrum Therapeutics Inc
$12.50-%
HEPAHepion Pharmaceuticals Inc
$0.0700-78.0%
HFFGHF Foods Group Inc
$2.56-%
HPEHewlett Packard Enterprise Co
$24.30-%
IFRXInflaRx NV
$1.03-0.96%
JGAurora Mobile Ltd
$6.71-0.59%
KRMDKORU Medical Systems Inc
$5.77-%
KZIAKazia Therapeutics Ltd
$9.50-4.90%
MOVMovado Group Inc
$21.81-%
MRKRMarker Therapeutics Inc
$1.280.79%
NIONIO Inc
$5.03-%
NTNXNutanix Inc
$48.26-0.02%
ORMPOramed Pharmaceuticals Inc
$3.090.33%
PANWPalo Alto Networks Inc
$187.09-%
PWPower REIT
$0.8678-8.01%
RAPTRAPT Therapeutics Inc
$34.03-%
RKDAArcadia Biosciences Inc
$3.57-1.92%
RRCRange Resources Corp
$34.45-%
SAFESafehold Inc
$13.62-%
TBLTToughBuilt Industries Inc
$0.0155-99.3%
TITNTitan Machinery Inc
$16.22-%
XENEXenon Pharmaceuticals Inc
$43.00-%
XFORX4 Pharmaceuticals Inc
$3.71-%
YAYOEVmo Inc
$0.00010-100.0%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
